ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $102,059 | +44.9% | 3,760 | +64.1% | 0.00% | – |
| Q2 2023 | $70,425 | -64.7% | 2,291 | -58.6% | 0.00% | – |
| Q1 2023 | $199,570 | +16.0% | 5,539 | +27.2% | 0.00% | – |
| Q4 2022 | $172,110 | -14.4% | 4,355 | -12.6% | 0.00% | – |
| Q3 2022 | $201,000 | -59.7% | 4,981 | -58.0% | 0.00% | -100.0% |
| Q2 2022 | $499,000 | +15.2% | 11,870 | +6.9% | 0.00% | 0.0% |
| Q1 2022 | $433,000 | +44.8% | 11,105 | +48.1% | 0.00% | – |
| Q4 2021 | $299,000 | +686.8% | 7,497 | +707.9% | 0.00% | – |
| Q2 2021 | $38,000 | -2.6% | 928 | +2.5% | 0.00% | – |
| Q1 2021 | $39,000 | -13.3% | 905 | 0.0% | 0.00% | – |
| Q4 2020 | $45,000 | +18.4% | 905 | 0.0% | 0.00% | – |
| Q3 2020 | $38,000 | -13.6% | 905 | 0.0% | 0.00% | – |
| Q2 2020 | $44,000 | – | 905 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |